48 results
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
participation in any state or federal health care program, or made subject to any pending or, to the Company’s knowledge, threatened or contemplated
8-K
EX-99.1
r66g39x
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
8-K
EX-1.1
r4w1g2h
15 Sep 22
Other Events
4:02pm
8-K
EX-99.1
xrdd07r1o d7
6 Apr 22
Regulation FD Disclosure
8:01am
S-3
EX-1.2
4pquzcn43x5h82rc0e
2 Nov 21
Shelf registration
5:21pm